[The use of otsid in treating patients with chronic gastroduodenitis and duodenal peptic ulcer].
Data are submitted of examination of 56 individuals (50 men and six women) in a clinical and diagnostic consultation center setting. The diagnosis was confirmed by results of fibrogastroduodenoscopy, ultrasonography of the abdominal organs, assay of the gastric secretion in endoscopic pH-metry, microscopic examination of smears-imprints for the presence of Helicobacter pylori in gastric mucosa. A comparative evaluation was done of efficacy of the course administration of ocide (omeprasole) in 26 patients with duodenal ulcer and 30 patients with chronic gastroduodenitis presenting with augmented secretion.
Lobenko
A A
AA
Gozhenko
A I
AI
Vasil'ev
V A
VA
D000328:Adult; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D002908:Chronic Disease; D003131:Combined Modality Therapy; D004341:Drug Evaluation; D004381:Duodenal Ulcer / Q000175:diagnosis / Q000188:drug therapy*; D004382:Duodenitis / Q000175:diagnosis / Q000188:drug therapy*; D005260:Female; D005756:Gastritis / Q000175:diagnosis / Q000188:drug therapy*; D016481:Helicobacter Infections / Q000175:diagnosis / Q000188:drug therapy; D016480:Helicobacter pylori; D006801:Humans; D008297:Male; D008875:Middle Aged; D009853:Omeprazole / Q000627:therapeutic use*
D000897:Anti-Ulcer Agents; D009853:Omeprazole
Primenenie otsida v lechenii bol'nykh khronicheskim gastroduodenitom i iazvennoĭ bolezn'iu dvenadtsatiperstnoĭ kishki.